Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Ecotoxicol Environ Saf ; 242: 113914, 2022 Sep 01.
Article in English | MEDLINE | ID: mdl-35878501

ABSTRACT

Silicosis is a systemic disease characterized by diffuse fibrosis of the lung tissue caused by long-term inhalation of large amounts of free silica (SiO2) dust. The pathogenesis of silicosis has not been fully elucidated, and there is a lack of effective treatment methods. N-acetylcysteine (NAC) can potentially treat pulmonary fibrosis by exerting antioxidant effects. Desipramine (DMI) can influence pulmonary fibrosis development by inhibiting acid sphingomyelinase (ASMase) activity and regulating ceramide concentrations. Both can interfere with pulmonary fibrosis through different mechanisms, but the intervention effects of NAC combined with DMI on silicosis fibrosis have not been reported. Therefore, this study established a rat silicosis model using a single tracheal drip of SiO2 dust suspension in Wistar rats to investigate the effect of NAC combined with DMI on SiO2 dust-induced silicosis and its related molecular mechanisms. The histopathological examination of the SiO2 dust-induced silicosis rats suggested that NAC and DMI alone or in combination could decrease the severity of pulmonary fibrosis in rats. The combined intervention had a better effect on reducing fibrosis than the individual interventions. NAC and DMI, alone or in combination, decreased the levels of markers related to pulmonary fibrosis in rats (smooth muscle α-actin (α-SMA), collagen (Col) I, Col III, hydroxyproline (HYP), inflammatory factors (transforming growth factor-ß1 (TGF-ß1) and tumor necrosis factor-α (TNF-α)), and lipid peroxidase malondialdehyde (MDA)). The nuclear factor-erythroid 2-related factor 2 (Nrf2)/heme-oxygenase-1 (HO-1) and ASMase/ceramide pathways were inhibited to some extent by increasing the superoxide dismutase (SOD) levels of antioxidant enzymes and 8-iso-prostaglandin F2α (8-iso-PGF2α) levels of lipid peroxides. The combined intervention and NAC alone inhibited the SiO2 dust-induced elevation of matrix metalloproteinase 1 (MMP-1) and tissue inhibitor matrix metalloproteinase 1 (TIMP-1), but the effect was not significant in the DMI-treated group. Combining DMI and NAC inhibited Col I deposition and reduced HO-1, TIMP-1, and ASMase levels in lung tissues compared to individual treatments. In summary, the SiO2 dust could induce oxidative stress and inflammation in rats, resulting in an imbalance in extracellular matrix (ECM) synthesis/catabolism and ASMase/ceramide signaling pathway activation, leading to silicosis development.The combined intervention of DMI and NAC may synergistically regulate the Nrf2/HO-1 pathway, maintain the anabolic balance of the ECM, inhibit ASMase/ceramide signaling pathway activation by suppressing the inflammatory response and effectively delay silicosis fibrosis progression.


Subject(s)
Acetylcysteine , Desipramine , Pulmonary Fibrosis , Silicosis , Acetylcysteine/metabolism , Acetylcysteine/pharmacology , Acetylcysteine/therapeutic use , Animals , Antioxidants/metabolism , Ceramides/metabolism , Desipramine/metabolism , Desipramine/therapeutic use , Disease Models, Animal , Drug Therapy, Combination , Dust , Fibrosis , Heme Oxygenase (Decyclizing) , Lung , Matrix Metalloproteinase 1/metabolism , Matrix Metalloproteinase 1/toxicity , NF-E2-Related Factor 2 , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/drug therapy , Pulmonary Fibrosis/metabolism , Rats , Rats, Wistar , Signal Transduction , Silicon Dioxide/toxicity , Silicosis/metabolism , Sphingomyelin Phosphodiesterase/metabolism , Sphingomyelin Phosphodiesterase/toxicity , Tissue Inhibitor of Metalloproteinase-1
2.
FASEB J ; 20(10): 1736-8, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16807369

ABSTRACT

Tat, the HIV transactivating protein, and matrix metalloproteinases (MMPs), a family of extracellular matrix (ECM) endopeptidases, have been implicated in the pathogenesis of HIV-associated dementia. However, the possibility that MMPs interact with viral proteins has remained unexplored. We therefore treated mixed human fetal neuronal cultures with recombinant Tat and select MMPs. Neurotoxicity was determined by measuring mitochondrial membrane potential and neuronal cell death. Previous studies have shown that Tat and MMP independently cause neurotoxicity. Surprisingly, we found the combination of Tat and MMP produced significant attenuation of neurotoxicity. To determine whether there was a physical interaction between Tat and MMP, we used protein electrophoresis and Western blot techniques, and found that MMP-1 can degrade Tat. This effect was blocked by MMP inhibitors. Furthermore, MMP-1 decreased Tat-mediated transactivation of the HIV long terminal repeat region, and this functionality was restored when MMP-1 activity was inhibited. These results suggest that the decrease in Tat-induced neurotoxicity and HIV transactivation is due to Tat's enzymatic cleavage by MMP-1. The direct interaction of human MMPs with viral proteins has now been demonstrated, with resultant modulation of Tat-mediated neurotoxicity and transactivation. This study elucidates a unique viral-host interaction that may serve as an innate host defense mechanism.


Subject(s)
Gene Products, tat/metabolism , Matrix Metalloproteinase 1/metabolism , Neurons/virology , Cells, Cultured , Dementia/etiology , Fetus/cytology , Gene Products, tat/toxicity , HIV Infections/complications , HIV Infections/immunology , HIV Long Terminal Repeat , Humans , Immunity , Matrix Metalloproteinase 1/toxicity , Membrane Potentials/drug effects , Mitochondrial Membranes/drug effects , Neurons/pathology , Protein Binding , Transcriptional Activation/drug effects , tat Gene Products, Human Immunodeficiency Virus
3.
Exp Neurol ; 163(2): 324-30, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10833306

ABSTRACT

Extracellular matrix (ECM) proteins, including collagens and laminins, are critical to the structure of the neuronal synapse and may also be involved in cell survival. In the present study, we therefore examined the possibility that select ECM degrading proteins might be toxic to organotypic spinal cord and dissociated neuronal cultures. Of those proteins tested, including MMP-1, -7, and -9, we observed that MMP-1 was toxic to spinal cord cultures as determined by release of lactic acid dehydrogenase as well as uptake of propidium iodide. Pretreatment of cell cultures with 50 microM alpha-tocopherol partially reversed these effects. We also observed that MMP-1 was toxic to human neurons grown in dissociated cultures and that increased amounts of MMP-1 were released by astrocytes following their stimulation with IL-1beta. These results suggest that further studies may be warranted to determine whether MMP-1 contributes to neurodegenerative conditions in which activated astrocytes may play a role.


Subject(s)
Astrocytes/metabolism , Matrix Metalloproteinase 1/toxicity , Matrix Metalloproteinase 7/toxicity , Matrix Metalloproteinase 9/toxicity , Neurons/drug effects , Spinal Cord/drug effects , Animals , Animals, Newborn , Astrocytes/drug effects , Cells, Cultured , Humans , Interleukin-1/pharmacology , L-Lactate Dehydrogenase/metabolism , Matrix Metalloproteinase 1/metabolism , Matrix Metalloproteinase Inhibitors , Neurons/metabolism , Rats , Recombinant Proteins/toxicity , Spinal Cord/metabolism , Vitamin E/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...